The Adenosinergic System - A Non-Dopaminergic Target in Parkinson's Disease (Paperback, Softcover reprint of the original 1st ed. 2015)

Adenosine A2A receptor antagonists have shown great promise in the treatment of Parkinson's Disease and alleviation of symptoms. This book addresses various aspects of this class of drugs from their chemical development to their clinical use. Among the many insightful chapters contained in this book, there are three unique reviews that have not previously been published in any format: (1) a history of istradefylline, the first A2A antagonist approved for treatment of Parkinson's Disease, (2) an overview of neuroimaging studies in human death and disease and (3) a study of urate as a possible biomarker and neuroprotectant.

General

Imprint:	Springer International Publishing AG
Country of origin:	Switzerland
Series:	Current Topics in Neurotoxicity, 10
Release date:	October 2016
First published:	2015
Editors:	Micaela Morelli • Nicola Simola • Jadwiga Wardas
Dimensions:	235 x 155 x 19mm (L x W x T)
Format:	Paperback
Pages:	337
Edition:	Softcover reprint of the original 1st ed. 2015
ISBN-13:	978-3-319-37186-3
Categories:	Books > Medicine > Clinical & internal medicine > Neurology & clinical neurophysiology
LSN:	3-319-37186-X
Barcode:	9783319371863

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!